DOI:
10.1055/s-00000089
Ultraschall in der Medizin - European Journal of Ultrasound
LinksClose Window
References
Escudier B, Lassau N, Angevin E. et al.
Phase I trial of sorafenib in combination with IFN alpha-2a in patients with unresectable and/or metastatic renal cell carcinoma or malignant melanoma.
Clin Cancer Res 2007;
13: 1801-1809
Access:
Access:
Access:
We do not assume any responsibility for the contents of the web pages of other providers.